* Surgery Partners Inc SGRY.OQ SGRY.O is expected
to show a
rise in quarterly revenue when it reports results on November
8.
* The Brentwood Tennessee-based company is expected to
report a
13.6% increase in revenue to $635.032 million from $559.2
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Surgery Partners
Inc is
for earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Surgery
Partners
Inc is $57, above its last closing price of $25.69.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.01 -0.01 -0.03 Missed -344.4
Mar. 31 2022 -0.06 -0.06 -0.09 Missed -47.5
Dec. 31 2021 0.21 0.19 0.23 Beat 18.7
Sep. 30 2021 -0.11 -0.10 -0.05 Beat 52.1
Jun. -0.20 -0.18 0.00 Beat 100
30 2021
Mar. 31 2021 -0.36 -0.37 -0.30 Beat 19.2
Dec. 31 2020 0.11 0.02 0.09 Beat 456.6
Sep. 30 2020 -0.39 -0.38 -0.53 Missed -40
This summary was machine generated November 4 at 19:41 GMT. All
figures in US dollars unless otherwise stated